The Indian Journal of Pediatrics

, Volume 84, Issue 9, pp 691–699 | Cite as

Extrahepatic Portal Venous Obstruction: What Should be the Mainstay of Treatment?

Review Article


The two cornerstones of management for Extrahepatic portal vein obstruction (EHPVO) are endotherapy and surgery [Porto-systemic shunts (PSS)/Mesorex bypass (MRB)]. Endotherapy is the mainstay of treatment for acute variceal bleed control and has also been used extensively for secondary prophylaxis till variceal eradication is achieved. However, long-term follow-up beyond endoscopic eradication of esophageal varices (EEEV) indicates that there are numerous delayed bleed and non bleed sequelae of EHPVO, which merit surgery as a definitive procedure to decompress the hypertensive portal venous system. While endotherapy obliterates natural porto-systemic collaterals in the gastroesophageal region, persistently raised portal pressures manifest as an increase in secondary isolated gastric varices, ectopic varices, portal hypertensive vasculopathy, issues related to massive splenomegaly, portal biliopathy, growth retardation and hence impaired quality of life (QOL). An ideal management strategy should address both bleed and non-bleed consequences of EHPVO and translate into a near normal QOL. Further, MRB has opened up new dimensions to the management philosophy of EHPVO. This review article critically evaluates the role of surgery and endotherapy based on available literature and authors’ own experience.

Surgery and endotherapy are complementary. However, with increasing duration of follow-up post EEEV, it is evident that there is resurgence in the role of surgery (PSS/MRB) as a single one time definitive procedure for alleviating all bleed and delayed non bleed sequelae of EHPVO.

Surgery for EHPVO (PSS/MRB) should not be allowed to become a dying art and future generations of surgeons should continue to receive training in this specialized area of surgery.


Extrahepatic portal vein obstruction Endotherapy Porto-systemic shunt surgery Mesorex bypass Long-term follow-up 



The authors deeply acknowledge the contribution of Prof. SK Yachha, Prof. VK Kapoor, Dr. SS Sikora, Dr. Anu Behari, Dr. Ujjal Poddar, Dr. Anshu Srivastava, and Dr. Ankur Mandelia for their tremendous clinical and research contributions in the arena of pediatric EHPVO at their centre.


RL: Conception & design, drafting of manuscript; MSS: Acquisition & analysis of data, critical intellectual input; MKG: Assisted in manuscript drafting, data acquisition. RL will act as guarantor for the paper.

Compliance with Ethical Standards

Conflict of Interest


Source of Funding



  1. 1.
    Sarin SK, Sollano JD, Chawla YK, et al; Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int. 2006;26:512–9.Google Scholar
  2. 2.
    Thomas V, Jose T, Kumar S. Natural history of bleeding after esophageal variceal eradication in patients with extrahepatic portal venous obstruction: a 20 year follow up. Indian J Gastroenterol. 2009;28:206–11.CrossRefPubMedGoogle Scholar
  3. 3.
    Maksoud-Filho JG, Gonçalves MEP, Cardoso SR, Gibelli NEM, Tannuri U. Long term follow up of children with extrahepatic portal vein obstruction: impact of an endoscopic sclerotherapy program on bleeding episodes, hepatic function, hypersplenism, and mortality. J Pediatr Surg. 2009;44:1877–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Zargar SA, Yattoo GN, Javid G, et al. Fifteen-year follow up of endoscopic injection sclerotherapy in children with extrahepatic portal venous obstruction. J Gastroenterol Hepatol. 2004;19:139–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Itha S, Yachha SK. Endoscopic outcome beyond esophageal variceal eradication in children with extrahepatic portal venous obstruction. J Pediatr Gastroenterol Nutr. 2006;42:196–200.CrossRefPubMedGoogle Scholar
  6. 6.
    Bismuth H, Franco D, Alagille D. Portal diversion for portal hypertension in children. The first ninety patients. Ann Surg. 1980;192:18–24.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odièvre M, Alagille D. Portal obstruction in children. II. Results of surgical portosystemic shunts. J Pediatr. 1983;103:703–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Mitra SK, Rao KLN, Narasimhan KL, et al. Side-to-side lienorenal shunt without splenectomy in non cirrhotic portal hypertension in children. J Pediatr Surg. 1993;28:398–402.CrossRefPubMedGoogle Scholar
  9. 9.
    Prasad AS, Gupta S, Kohli V. Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg. 1994;219:193–6.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Orloff MJ, Orloff MS, Barbara G. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years experience with porto-systemic shunt. J Am Coll Surg. 2002;194:717–28.CrossRefPubMedGoogle Scholar
  11. 11.
    Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA. Advantages of the meso-rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children. J Am Coll Surg. 2013;216:83–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Shneider BL, de Ville de Goyet J, Leung DH, et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI pediatric satellite symposium. Hepatology. 2016;63:1368–80.Google Scholar
  13. 13.
    Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol. 2000;95:768–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Zargar SA, Javid G, Khan BA, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology. 2002;36:666–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Yachha SK, Ghoshal UC, Gupta R, Sharma BC, Ayyagari A. Portal hypertensive enteropathy in children with extrahepatic portal venous obstruction: role of variceal obliteration by endoscopic sclerotherapy and Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 1996;23:20–3.Google Scholar
  16. 16.
    Chaudhary A, Aranya RC. Devascularization following endoscopic sclerotherapy of esophageal varices: dangers and difficulties. Br J Surg. 1991;78:1249–51.CrossRefPubMedGoogle Scholar
  17. 17.
    Chaudhary A, Tatke M, Aranya RC. Endoscopic sclerotherapy: the far and near effects. Br J Surg. 1990;77:963.CrossRefPubMedGoogle Scholar
  18. 18.
    Yachha SK, Dhiman RK, Gupta R, Ghoshal UC. Endosonographic evaluation of the rectum in children with extrahepatic portal venous obstruction. J Pediatr Gastroenterol Nutr. 1996;23:438–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Krishna YR, Yachha SK, Srivastava A, Negi D, Lal R, Poddar U. Quality of life in children managed for extrahepatic portal venous obstruction. J Pediatr Gastroenterol Nutr. 2010;50:531–6.PubMedGoogle Scholar
  20. 20.
    Gauthier-Villars M, Franchi S, Gauthier F, Fabre M, Pariente D, Bernard O. Cholestasis in children with portal vein obstruction. J Pediatr. 2005;146:568–73.CrossRefPubMedGoogle Scholar
  21. 21.
    Menon P, Rao KLN, Bhattacharya A, et al. Extrahepatic portal hypertension: quality of life and somatic growth after surgery. Eur J Pediatr Surg. 2005;15:82–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Sarin SK, Bansal A, Sasan S, Nigam A. Portal-vein obstruction in children leads to growth retardation. Hepatology. 1992;15:229–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Wani AH, Shah OJ, Zargar SA. Management of variceal hemorrhage in children with extrahepatic portal venous obstruction-shunt surgery versus endoscopic sclerotherapy. Indian J Surg. 2011;73:409–13.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Rao KLN, Goyal A, Menon P. Extrahepatic portal hypertension in children: observations on three surgical procedures. Pediatr Surg Int. 2004;20:679–84.CrossRefPubMedGoogle Scholar
  25. 25.
    de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.CrossRefPubMedGoogle Scholar
  26. 26.
    Sen Sarma M, Lal R, Yachha SK, Behari A, Srivastava A. Portosystemic shunt surgery for extrahepatic portal vein obstruction in children: shifting indications beyond endoscopic variceal eradication (abstract OP285). Abstracts of the 26th Annual Conference of APASL 2017. Hepatol Int. 2017;11:S181.Google Scholar
  27. 27.
    Vibert E, Azoulay D, Aloia T, et al. Therapeutic strategies in symptomatic portal biliopathy. Ann Surg. 2007;246:97–104.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chaudhary A, Dhar P, Sarin SK, et al. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg. 1998;85:326–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Kato T, Romero R, Koutouby R, et al. Portosystemic shunting in children during the era of endoscopic therapy: improved post operative growth parameters. J Pediatr Gastroenterol Nutr. 2000;30:419–25.CrossRefPubMedGoogle Scholar
  30. 30.
    Mehrotra RN, Bhatia V, Dabadghao P, Yachha SK. Extrahepatic portal vein obstruction in children: anthropometry, growth hormone and insulin like growth factor I. J Pediatr Gastroenterol Nutr. 1997;25:520–3.CrossRefPubMedGoogle Scholar
  31. 31.
    Mohapatra MK, Mohapatra AK, Acharya SK, Sahni P, Nundy S. Encephalopathy in patients with extrahepatic obstruction after lienorenal shunts. Br J Surg. 1992;79:1103–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Yadav SK, Srivastava A, Srivastava A, et al. Encephalopathy assessment in children with extrahepatic portal vein obstruction with MR, psychometry and critical flicker frequency. J Hepatol. 2010;52:348–54.CrossRefPubMedGoogle Scholar
  33. 33.
    Srivastava A, Yadav SK, Lal R, et al. Effect of surgical portosystemic shunt on prevalence of minimal hepatic encephalopathy in children with extrahepatic portal venous obstruction: assessment by magnetic resonance imaging and psychometry. J Pediatr Gastroenterol Nutr. 2010;51:766–72.CrossRefPubMedGoogle Scholar
  34. 34.
    Luoto T, Pakarinen M, Mattila I, Rintala R. Mesoportal bypass using a constructed saphenous vein graft for extrahepatic portal vein obstruction--technique, feasibility and outcome. J Pediatr Surg. 2012;47:688–93.CrossRefPubMedGoogle Scholar
  35. 35.
    Guérin F, Bidault V, Gonzales E, Franchi-Abella S, De Lambert G, Branchereau S. Mesorex bypass for extrahepatic portal vein obstruction in children. Br J Surg. 2013;100:1606–13.CrossRefPubMedGoogle Scholar
  36. 36.
    Sharif K, McKiernan P, de Ville de Goyet J. Mesoportal bypass for extrahepatic portal vein obstruction in children: close to a cure for most! J Pediatr Surg. 2010;45:272–6.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2017

Authors and Affiliations

  • Richa Lal
    • 1
  • Moinak Sen Sarma
    • 2
  • Manish K. Gupta
    • 1
  1. 1.Department of Pediatric Surgical SuperspecialtiesSanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia
  2. 2.Department of Pediatric GastroenterologySanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations